Medical Condition News

RSS

Free radicals may damage eyes of patients with Fuchs Endothelial Corneal Dystrophy

Scientists have found that free radicals (unstable molecules that cause the death of cells as the body ages) may also cause the damage in the eyes of patients with Fuchs Endothelial Corneal Dystrophy (FECD), a hereditary disease that is one of the most common reasons for corneal transplants worldwide.

1 Feb 2011

Sprint Fidelis ICD leads fail more often in younger patients with hereditary heart disease

The recalled Sprint Fidelis implantable cardioverter-defibrillator leads failed more often in younger patients, women, and individuals with hereditary heart disease, according to a multicenter study published online Jan. 17 in Circulation. The researchers found that lead failure was not associated with death or serious injuries.

1 Feb 2011

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

BioMimetic Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled an Orthopedic and Rehabilitation Devices Panel meeting on May 12, 2011 to review the Company's Premarket Approval (PMA) application for Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S.

1 Feb 2011

CINJ Foundation, Panera Bread enter joint venture to fight against cancer

Panera Bread has expanded its contributions to the fight against cancer by selecting the Cancer Institute of New Jersey Foundation as its Community Breadbox Partner for 2011.

1 Feb 2011

Favorable clinical results from Endologix's Nellix technology against EVAR

Endologix, developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm.

1 Feb 2011

Research on triple negative disease can benefit patients with breat cancer

Research to develop more effective treatments for triple negative breast cancer -- a difficult disease to cure -- could someday benefit all breast cancer patients, reports Dr. Frederick C. Tucker, Jr. of Fredericksburg Oncology.

1 Feb 2011

Fortis Hospital specialists in Mumbai successfully perform gastric bypass surgery in American patient

Specialists at Fortis Hospitals Mumbai successfully diagnosed and treated a previously undetected pituitary tumor in Michelle Hardin, a 35 year-old American medical traveler.

1 Feb 2011

Simple hTERT analysis may provide useful prognostic tool in advanced non-small cell lung cancer

High levels of circulating DNA may indicate faster progression of lung cancer and lower overall survival, according to a study published in the February edition of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC).

1 Feb 2011

Study finds E2F5 transcription factor commonly overexpressed in primary human HCC

E2F5 is a member of the E2F transcription factor family, and plays a key role in cell growth and proliferation. Overexpression of E2F5 has been reported in various human cancers, but not in liver cancer, and its biological implication is largely unknown. It is not known whether E2F5 plays a tumor suppressor role or an oncogenic role.

1 Feb 2011

IASLC publishes new international multidisciplinary classification for lung adenocarcinoma

Three of the world's top lung associations have published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.

1 Feb 2011

Researchers propose new classification system for SOD

Sphincter of Oddi dysfunction is a pathological syndrome that is usually classified into the biliary type or the pancreatic type according to the Milwaukee criteria.

1 Feb 2011

News briefs from February issue of journal Chest

New research shows that vitamin D deficiency is prevalent among patients with interstitial lung disease (ILD), with the largest prevalence seen in patients with concurrent connective tissue disease (CTD).

1 Feb 2011

Scientists create 'reporter mouse' to close gap between kidney injury and diagnosis

The current check for kidney disease is a simple blood test for serum creatinine, but it can take longer than two days for this metabolite to accumulate to levels that are significant enough to indicate kidney damage - and by then it may be too late to intervene.

1 Feb 2011

New study finds link between race and treatment delay in women with breast cancer

At a time when access to prompt treatment might affect survival, a large new study finds that African-American and Hispanic women newly diagnosed with breast cancer often face delays in care of more than a month.

1 Feb 2011

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that it has received approval from Health Canada for the Acculis Accu2i percutaneous microwave tissue ablation system for the coagulation of soft tissue during surgical procedures.

1 Feb 2011

Research sheds new light on venous thromboembolism following liver resections

Patients undergoing liver surgery have long been considered to be at low risk of venous thromboembolism. However, pulmonary embolism has recently emerged as an increasingly frequent and potentially fatal complication following liver resections.

1 Feb 2011

Positive results from NRM8499 phase I clinical study in patients with Alzheimer's disease

BELLUS Health announced today the results of the phase I clinical study for NRM8499, a prodrug of tramiprosate, intended for the treatment of Alzheimer's disease.

1 Feb 2011

Mayo Clinic opens new center to deliver optimal health care solutions

Mayo Clinic announced the launch of a new initiative focused on creating new and improved approaches to delivering health care. The Center for the Science of Health Care Delivery will design, implement, measure and disseminate high-value health care best practices with initial focus areas that include wellness and the prediction, prevention, and management of chronic diseases.

1 Feb 2011

$FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma$

FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma

Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.

1 Feb 2011

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

ImaginAb, and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia pastoris expression system.

1 Feb 2011

Medical Condition News

Free radicals may damage eyes of patients with Fuchs Endothelial Corneal Dystrophy

Sprint Fidelis ICD leads fail more often in younger patients with hereditary heart disease

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

CINJ Foundation, Panera Bread enter joint venture to fight against cancer

Favorable clinical results from Endologix's Nellix technology against EVAR

Research on triple negative disease can benefit patients with breat cancer

Fortis Hospital specialists in Mumbai successfully perform gastric bypass surgery in American patient

Simple hTERT analysis may provide useful prognostic tool in advanced non-small cell lung cancer

Study finds E2F5 transcription factor commonly overexpressed in primary human HCC

IASLC publishes new international multidisciplinary classification for lung adenocarcinoma

Researchers propose new classification system for SOD

News briefs from February issue of journal Chest

Scientists create 'reporter mouse' to close gap between kidney injury and diagnosis

New study finds link between race and treatment delay in women with breast cancer

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Research sheds new light on venous thromboembolism following liver resections

Positive results from NRM8499 phase I clinical study in patients with Alzheimer's disease

Mayo Clinic opens new center to deliver optimal health care solutions

FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News